WGS Q1 2024 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena

WGSGeneDx Holdings Corp.

$3B

Q1 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$62M+44.7% YoY

Gross Profit

$37M59.9% margin

Operating Income

-$14M-21.9% margin

Net Income

-$20M-32.4% margin

EPS (Diluted)

$-0.78

QoQ Revenue Growth

+8.7%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

-$451,000

Balance Sheet

Total Assets

$395M

Total Liabilities

$187M

Stockholders' Equity

$207M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62M	$43M	+44.7%
Gross Profit	$37M	$15M	+145.5%
Operating Income	-$14M	-$60M	+77.4%
Net Income	-$20M	-$61M	+66.8%